Tanshinone IIA activates calcium-dependent apoptosis signaling pathway in human hepatoma cells

Journal of Natural Medicines

Volumn 66, Issue 1, 2012, Pages 192-201

  Dai, Zhi Kai ^a   Qin, Jiang Ke ^b   Huang, Jiao E ^a   Luo, Yong ^c   Xu, Qing ^a   Zhao, Hai Lu ^a  

^a GUILIN MEDICAL UNIVERSITY   (China)

^b GUANGXI NORMAL UNIVERSITY   (China)

^c Department of Neurology   (China)

Author keywords

Apoptosis; Calcium dependent pathway; Human amniotic mesenchymal stem cell; Human hepatoma BEL 7402 cell line; Metallothionein 1A; Tanshinone IIA

Indexed keywords

CALCIUM; MESSENGER RNA; METALLOTHIONEIN I; TANSHINONE IIA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CANCER CELL; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYMAL STEM CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALVIA MILTIORRHIZA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; CALCIUM SIGNALING; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DITERPENES, ABIETANE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HUMANS; LIVER NEOPLASMS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MESENCHYMAL STEM CELLS; METALLOTHIONEIN; MICROSCOPY, FLUORESCENCE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 84856219184     PISSN: 13403443     EISSN: 18610293     Source Type: Journal    
DOI: 10.1007/s11418-011-0576-0     Document Type: Article

References (53)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917
2. Farazi PA, DePinho RA (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6:674-687 (Pubitemid 44286000)
3. Zhou L, Zuo Z, Chow MS (2005) Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 45:1345-1359 (Pubitemid 41643896)
4. Niu XL, Ichimori K, Yang X, Hirota Y, Hoshiai K, Li M, Nakazawa H (2000) Tanshinone II-A inhibits low density lipoprotein oxidation in vitro. Free Radic Res 33:305-312
5. Yan FF, Liu YF, Liu Y, Zhao YX (2009) Sulfotanshinone Sodium Injection could decrease fibrinogen level and improve clinical outcomes in patients with unstable angina pectoris. Int J Cardiol 135:254-255
6. Dong X, Dong J, Zhang R, Fan L, Liu L, Wu G (2009) Antiinflammatory effects of tanshinone IIA on radiation-induced microglia BV-2 cells inflammatory response. Cancer Biother Radiopharm 24:681-687
7. Kapoor S (2009) Tanshinone IIA: a potent, natural anti-carcinogenic agent for the management of systemic malignancies. Chin J Integr Med 15:153
8. Yoon Y, Kim YO, Jeon WK, Park HJ, Sung HJ (1999) Tanshinone IIA isolated from Salvia miltiorrhiza BUNGE induced apoptosis in HL60 human premyelocytic leukemia cell line. J Ethnopharmacol 68:121-127 (Pubitemid 29502468)
9. Lee WY, Cheung CC, Liu KW, Fung KP, Wong J, Lai PB, Yeung JH (2010) Cytotoxic effects of tanshinones from Salvia miltiorrhiza on doxorubicin-resistant human liver cancer cells. J Nat Prod 73:854-859
10. Tang Z, Tang Y, Fu L (2003) Growth inhibition and apoptosis induction in human hepatoma cells by tanshinone II A. J Huazhong Univ Sci Technol Med Sci 23:166-168, 172
11. Zhu B, Zhai Q, Yu B (2010) Tanshinone IIA protects rat primary hepatocytes against carbon tetrachloride toxicity via inhibiting mitochondria permeability transition. Pharm Biol 48:484-487
12. Shi SL, Li QF, Liu QR, Xu DH, Tang J, Liang Y, Zhao ZL, Yang LM (2009) Nuclear matrix protein, prohibitin, was down-regulated and translocated from nucleus to cytoplasm during the differentiation of osteosarcoma MG-63 cells induced by ginsenoside Rg1, cinnamic acid, and tanshinone IIA (RCT). J Cell Biochem 108:926-934
13. Yeruva L, Hall C, Elegbede JA, Carper SW (2010) Perillyl alcohol and methyl jasmonate sensitize cancer cells to cisplatin. Anticancer Drugs 21:1-9
14. Ward MW, Rego AC, Frenguelli BG, Nicholls DG (2000) Mitochondrial membrane potential and glutamate excitotoxicity in cultured cerebellar granule cells. J Neurosci 20:7208-7219
15. Ni X, Sullivan GJ, Martin-Caraballo M (2007) Developmental characteristics of AMPA receptors in chick lumbar motoneurons. Dev Neurobiol 67:1419-1432 (Pubitemid 350067588)
16. Miao Z, Jin J, Chen L, Zhu J, Huang W, Zhao J, Qian H, Zhang X (2006) Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol Int 30:681-687 (Pubitemid 44331625)
17. Mizokami T, Hisha H, Okazaki S, Takaki T, Wang XL, Song CY, Li Q, Kato J, Hosaka N, Inaba M, Kanzaki H, Ikehara S (2009) Preferential expansion of human umbilical cord blood-derived CD34-positive cells on major histocompatibility complex-matched amnion-derived mesenchymal stem cells. Haematologica 94:618-628
18. Yuan SL, Wei YQ, Wang XJ, Xiao F, Li SF, Zhang J (2004) Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cells. World J Gastroenterol 10:2024-2028 (Pubitemid 39106951)
19. Wang ZY (2003) Ham-Wasserman lecture: treatment of acute leukemia by inducing differentiation and apoptosis. Hematology Am Soc Hematol Educ Program 1-13
20. Wang X, Yuan S, Wang C (1996) A preliminary study of the anticancer effect of tanshinone on hepatic carcinoma and its mechanism of action in mice. Zhonghua Zhong Liu Za Zhi 18:412-414
21. Soleimanpour SA, Crutchlow MF, Ferrari AM, Raum JC, Groff DN, Rankin MM, Liu C, De Leon DD, Naji A, Kushner JA, Stoffers DA (2010) Calcineurin signaling regulates human islet {beta}-cell survival. J Biol Chem 285:40050-40059
22. Wang X, Wei Y, Yuan S, Liu G, Lu Y, Zhang J, Wang W (2005) Potential anticancer activity of tanshinone IIA against human breast cancer. Int J Cancer 116:799-807 (Pubitemid 41099713)
23. Liu Y, Chen H, Jiang Y (2001) Protective effect of tanshinone IIA on acute hepatic injury in mice. Zhong Yao Cai 24:588-589
24. Liu Y, Wang X (2003) Protective effects of tanshinone IIA on injured primary cultured rat hepatocytes induced by CCl4. Zhong Yao Cai 26:415-417
25. Lu Q, Zhang P, Zhang X, Chen J (2009) Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer. Int J Mol Med 24:773-780
26. Olofsson MH, Havelka AM, Brnjic S, Shoshan MC, Linder S (2008) Charting calcium-regulated apoptosis pathways using chemical biology: role of calmodulin kinase II. BMC Chem Biol 8:2
27. Williams JP, Micoli K, McDonald JM (2010) Calmodulin - an often-ignored signal in osteoclasts. Ann N Y Acad Sci 1192:358-364
28. Devireddy LR, Green MR (2003) Transcriptional program of apoptosis induction following interleukin 2 deprivation: identification of RC3, a calcium/calmodulin binding protein, as a novel proapoptotic factor. Mol Cell Biol 23:4532-4541 (Pubitemid 36734744)
29. Crabtree GR (2001) Calcium, calcineurin, and the control of transcription. J Biol Chem 276:2313-2316
30. Shibasaki F, McKeon F (1995) Calcineurin functions in Ca(2+)- activated cell death in mammalian cells. J Cell Biol 131:735-743
31. 2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284:339-343
32. Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI, Adams JM, Huang DC (2005) Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19:1294-1305 (Pubitemid 41003019)
33. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292:727-730 (Pubitemid 32385543)
34. Shimizu S, Narita M, Tsujimoto Y (1999) Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399:483-487 (Pubitemid 29258855)
35. Sullivan PG, Dragicevic NB, Deng JH, Bai Y, Dimayuga E, Ding Q, Chen Q, Bruce-Keller AJ, Keller JN (2004) Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover. J Biol Chem 279:20699-20707 (Pubitemid 38656466)
36. Rivera A, Maxwell SA (2005) The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway. J Biol Chem 280:29346-29354 (Pubitemid 41161390)
37. Chiu TL, Su CC (2010) Tanshinone IIA induces apoptosis in human lung cancer A549 cells through the induction of reactive oxygen species and decreasing the mitochondrial membrane potential. Int J Mol Med 25:231-236
38. Sastry KS, Smith AJ, Karpova Y, Datta SR, Kulik G (2006) Diverse antiapoptotic signaling pathways activated by vasoactive intestinal polypeptide, epidermal growth factor, and phosphatidylinositol 3-kinase in prostate cancer cells converge on BAD. J Biol Chem 281:20891-20901 (Pubitemid 44115430)
39. She QB, Solit DB, Ye Q, O'Reilly KE, Lobo J, Rosen N (2005) The BAD protein integrates survival signaling by EGFR/MAPK and PI3 K/Akt kinase pathways in PTEN-deficient tumor cells. Cancer Cell 8:287-297 (Pubitemid 41443414)
40. Theocharis SE, Margeli AP, Klijanienko JT, Kouraklis GP (2004) Metallothionein expression in human neoplasia. Histopathology 45:103-118 (Pubitemid 39120406)
41. Alonso-Gonzalez C, Mediavilla D, Martinez-Campa C, Gonzalez A, Cos S, Sanchez-Barcelo EJ (2008) Melatonin modulates the cadmium-induced expression of MT-2 and MT-1 metallothioneins in three lines of human tumor cells (MCF-7, MDA-MB-231 and HeLa). Toxicol Lett 181:190-195
42. Saito T, Tezuka T, Konno R, Fujii N (2010) Protective effects of metallothionein I and II against metal- and ultraviolet radiationinduced damage in cultured lens epithelial cells. Jpn J Ophthalmol 54:486-493
43. Majumder S, Roy S, Kaffenberger T, Wang B, Costinean S, Frankel W, Bratasz A, Kuppusamy P, Hai T, Ghoshal K, Jacob ST (2010) Loss of metallothionein predisposes mice to diethylnitrosamine- induced hepatocarcinogenesis by activating NFkappaB target genes. Cancer Res 70:10265-10276
44. de Gruijl FR (2000) Photocarcinogenesis: UVA vs UVB. Methods Enzymol 319:359-366 (Pubitemid 30448057)
45. Ioachim E, Assimakopoulos D, Peschos D, Zissi A, Skevas A, Agnantis NJ (1999) Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen. Pathol Res Pract 195:809-814
46. Klaassen CD, Liu J, Choudhuri S (1999) Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu Rev Pharmacol Toxicol 39:267-294 (Pubitemid 29222560)
47. Hu R, Hebbar V, Kim BR, Chen C, Winnik B, Buckley B, Soteropoulos P, Tolias P, Hart RP, Kong AN (2004) In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat. J Pharmacol Exp Ther 310:263-271 (Pubitemid 38812720)
48. Yeh CT, Yen GC (2005) Effect of sulforaphane on metallothionein expression and induction of apoptosis in human hepatoma HepG2 cells. Carcinogenesis 26:2138-2148
49. Cherian MG, Jayasurya A, Bay BH (2003) Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res 533:201-209 (Pubitemid 37487869)
50. Krizkova S, Masarik M, Majzlik P, Kukacka J, Kruseova J, Adam V, Prusa R, Eckschlager T, Stiborova M, Kizek R (2010) Serum metallothionein in newly diagnosed patients with childhood solid tumours. Acta Biochim Pol 57:561-566
51. Yap X, Tan HY, Huang J, Lai Y, Yip GW, Tan PH, Bay BH (2009) Over-expression of metallothionein predicts chemoresistance in breast cancer. J Pathol 217:563-570
52. Jin R, Huang J, Tan PH, Bay BH (2004) Clinicopathological significance of metallothioneins in breast cancer. Pathol Oncol Res 10:74-79 (Pubitemid 38915598)
53. Xia WJ, Yang M, Fok TF, Li K, Chan WY, Ng PC, Ng HK, Chik KW, Wang CC, Gu GJ, Woo KS, Fung KP (2005) Partial neuroprotective effect of pretreatment with tanshinone IIA on neonatal hypoxia-ischemia brain damage. Pediatr Res 58:784-790 (Pubitemid 41368914)